The Aires Technology Patent: WO 2021/064446 and US12239835B2
The Aires Technology Patent: US12239835B2
PCT Filed: October 1, 2019 | PCT Published: April 8, 2021 | US Granted: March 4, 2025
On March 4, 2025, the United States Patent and Trademark Office granted US12239835B2 to American Aires Inc. — the culmination of a patent program that began with the filing of international application PCT/IB2019/058334 (published as WO 2021/064446 A1) in October 2019. This patent protects the core method underlying all Lifetune products: the transformation of technogenic electromagnetic radiation into coherent electromagnetic radiation using a fractal-matrix resonator.
Patent Identifiers
| Field | Value |
|---|---|
| US Patent Number | US12239835B2 |
| Grant Date | March 4, 2025 |
| Assignee | American Aires Inc. |
| Inventor | Igor Serov [RU/ES] |
| PCT Application Number | PCT/IB2019/058334 |
| PCT Publication | WO 2021/064446 A1 |
| PCT Filing Date | October 1, 2019 |
| PCT Publication Date | April 8, 2021 |
| International Classification | A61N 1/16 (2006.01) |
| PCT Agent | Otilija Klimaitiene (Vilnius, Lithuania) |
What the Patent Protects
The patent protects a method — the specific process of using a fractal-matrix coherent transformer to convert incoming technogenic electromagnetic radiation into coherent electromagnetic radiation. This is meaningful because method patents are generally broader than device patents: the claims cover the transformation process regardless of the exact physical implementation, as long as a fractal-matrix coherent transformer is used.
The patent does not claim blocking or shielding of EM radiation. The technology is a transformation technology: it converts radiation from its ambient technogenic form (characterized by incoherent amplitude, phase, frequency, and polarization vectors) into coherent radiation — a spatial holographic matrix of harmonized electromagnetic wave superpositions surrounding the biological object.
The Nine Patent Claims
The patent as amended (Article 19 amendments, received October 1, 2020) contains nine claims:
- Claim 1 (independent): A method for transforming electromagnetic radiation within a range of frequencies into coherent electromagnetic radiation, comprising applying a fractal-matrix coherent transformer to the electromagnetic radiation.
- Claim 2: The method of Claim 1, wherein the fractal-matrix coherent transformer comprises a self-affine lattice of annular topological lines and a slit-like raster structure on its surface.
- Claim 3: The method of Claim 2, wherein the coherent transformer forms an electromagnetic field in the form of a regular spatial holographic matrix.
- Claim 4: The method of Claim 3, wherein the fractal-matrix coherent transformer transforms technogenic electromagnetic radiation of a biological object into a spatial coherent matrix of harmonized superpositions of electromagnetic waves.
- Claim 5: The method of Claim 1, wherein the fractal-matrix coherent transformer is placed on a biological object.
- Claim 6: The method of Claim 1, wherein the fractal-matrix coherent transformer is placed on a source of electromagnetic radiation.
- Claim 7: The method of Claim 1, wherein the fractal-matrix coherent transformer is placed between a biological object and a source of electromagnetic radiation.
- Claim 8: The method of any preceding claim, wherein the range of frequencies is from 2.4 GHz to 28 GHz.
- Claim 9: The method of any preceding claim, wherein the electromagnetic radiation is from technical devices and systems.
Technical Mechanism (as Described in the Patent Specification)
The patent specification describes the operating mechanism in physical terms. The fractal-matrix resonator functions as a Fourier transformer by virtue of its self-affine surface geometry. When electromagnetic radiation impinges upon the fractal surface, the resonator harmonizes the amplitude, phase, frequency, and polarization vectors of the incoming radiation. The output is a coherent electromagnetic matrix — a holographic spatial field — surrounding the biological object.
Key physical parameters specified in the patent:
- Ring groove depth: approximately 1.3 micrometers (μm)
- Ring groove width: approximately 1 μm
- Minimum spacing between grooves: 1 μm
- Wafer outer diameter: 6 mm
- Operating frequency range: 2.4 GHz to 28 GHz (covering WiFi 2.4 GHz and 5 GHz, LTE, and 5G mmWave bands)
The self-affine (fractal) geometry is fundamental to the broadband operation. Unlike a flat mirror or Faraday cage, the fractal surface operates across a wide spectrum through its scale-invariant structure: each annular topological line resonates at a slightly different frequency within the fractal progression, enabling coherence transformation across the entire 2.4–28 GHz range simultaneously.
International Classification and Technical Context
The patent is classified under IPC A61N 1/16 — “Electrotherapy; therapy using electric current of special waveform.” This classification situates the invention within the medical devices and biophysics domain rather than purely materials science or electronics. It connects the technology to a body of prior art addressing electromagnetic interaction with biological systems — consistent with the supporting independent research program.
Prior Art Chain: Russian Foundational Patents
The patent specification and the International Search Report (ISR) both cite Russian invention patents as Category X prior art — documents “particularly relevant to the claimed invention, taken alone.” These are the foundational patents that established the coherent transformer concept before the PCT application:
| Patent | Year | Cited As |
|---|---|---|
| RU2231137 | 2004 | ISR Category X; cited in specification — foundational coherent transformer patent establishing the core concept |
| RU2200968 | 2003 | ISR Category X (most relevant prior art) |
| RU2308065 | 2007 | ISR Category X (most relevant prior art) |
| RU2284062 | ~2006 | Cited in specification as prior art |
| RU2217181 | ~2003 | Cited in specification as prior art |
The PCT application is therefore the international stage of a patent program that began in Russia around 2000 and has been systematically commercialized and internationalized over the following twenty-five years. The Russian patents are the subject of the Founder IP Assignment Agreement by which the inventor’s foundational IP was transferred to American Aires Inc.
The supporting materials science research program (2002–2017) directly characterizes the physical properties of the resonator described in these patents. Papers by Tomilin & Serov (2002, Optics & Spectroscopy), Serov & Moshnikov (2003), Serov & Margolin (2004, 2005), and Lukyanov (2017, HOLOEXPO) provide experimental and theoretical characterization of the fractal-matrix structure at the nanoscale level. See Physics and Engineering Research for the full progression.
Relationship to the Research Program
The patent describes the technology; the independent research program documents the biological consequences. The 95+ peer-reviewed and institutional studies indexed in the Aires Research Overview address the downstream question: given that the fractal-matrix resonator transforms EM radiation into coherent form, what happens to biological systems exposed to that coherent radiation compared to the original technogenic radiation?
The two bodies of evidence are complementary: the patent establishes the physical mechanism (what the device does); the research establishes the significance (what the transformation means for biological systems exposed to WiFi, 4G, and 5G radiation).
Complete IP Portfolio
This technology patent is one component of a broader international portfolio. For the full picture including design patents (US, Canada, EU, UK, Russia) and trademark registrations (LIFETUNE™, AMERICAN AIRES™, and six additional AIRES brand names), see: American Aires Inc. Intellectual Property Portfolio.